Clinical Trial Update: Re-challenge Therapy With Chemotherapy & Panitumumab in Metastatic Colorectal Cancer Patients Treated With an Anti-EGFR [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating re-challenge therapy with chemotherapy and panitumumab in metastatic colorectal cancer patients previously treated with an ant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: King Abdullah Medical City | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: UNKNOWN